![Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire](https://mms.businesswire.com/media/20210831005934/en/902034/23/MedinCell_LOGO.jpg)
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
![FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults](https://www.drugs.com/images/pills/custom/pill34469-1/uzedy.jpeg)
FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults
![Risperidone Teva 25 mg, proszek i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań o przedłużonym uwalnianiu, 1 zestaw | Allecco.pl Risperidone Teva 25 mg, proszek i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań o przedłużonym uwalnianiu, 1 zestaw | Allecco.pl](https://www.allecco.pl/public/i/id/prescription-new.jpg)
Risperidone Teva 25 mg, proszek i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań o przedłużonym uwalnianiu, 1 zestaw | Allecco.pl
![FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1320998287/image_1320998287.jpg?io=getty-c-crop-4-3)